Diabetes in a Large Dementia Cohort: Clinical Characteristics and Treatment From the Swedish Dementia Registry
Open Access
- 27 June 2017
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 40 (9) , 1159-1166
Abstract
OBJECTIVE: We aimed to investigate the differences in clinical characteristics and pharmacological treatment associated with the presence of diabetes in a large cohort of patients with dementia. RESEARCH DESIGN AND METHODS: A cross-sectional registry-based study was conducted using data from the Swedish Dementia Registry (SveDem). Data on dementia diagnosis, dementia type, and demographic determinants were extracted from SveDem. Data from the Swedish Patient Register and Prescribed Drug Register were combined for the diagnosis of diabetes. Data on antidiabetic, dementia, cardiovascular, and psychotropic medications were extracted from the Swedish Prescribed Drug Register. Logistic regression was used to determine whether the variables were associated with diabetes after adjustment for confounders. In total, 29,630 patients were included in the study, and 4,881 (16.5%) of them received a diagnosis of diabetes. RESULTS: In the fully adjusted model, diabetes was associated with lower age at dementia diagnosis (odds ratio [OR] 0.97 [99% CI 0.97–0.98]), male sex (1.41 [1.27–1.55]), vascular dementia (1.17 [1.01–1.36]), and mixed dementia (1.21 [1.06–1.39]). Dementia with Lewy bodies (0.64 [0.44–0.94]), Parkinson disease dementia (0.46 [0.28–0.75]), and treatment with antidepressants (0.85 [0.77–0.95]) were less common among patients with diabetes. Patients with diabetes who had Alzheimer disease obtained significantly less treatment with cholinesterase inhibitors (0.78 [0.63–0.95]) and memantine (0.68 [0.54–0.85]). CONCLUSIONS: Patients with diabetes were younger at dementia diagnosis and obtained less dementia medication for Alzheimer disease, suggesting less optimal dementia treatment. Future research should evaluate survival and differences in metabolic profile in patients with diabetes and different dementia disorders.Keywords
Funding Information
- Swedish Research Council (2012-2291)
This publication has 43 references indexed in Scilit:
- The use of cholinesterase inhibitors and the risk of myocardial infarction and death: a nationwide cohort study in subjects with Alzheimer's diseaseEuropean Heart Journal, 2013
- Differences in Drug Therapy between Dementia Disorders in the Swedish Dementia Registry: A Nationwide Study of over 7,000 PatientsDementia and Geriatric Cognitive Disorders, 2013
- External review and validation of the Swedish national inpatient registerBMC Public Health, 2011
- Diabetes, Alzheimer disease, and vascular dementiaNeurology, 2010
- Ageing populations: the challenges aheadThe Lancet, 2009
- Diabetes and the Risk of Multi-System Aging Phenotypes: A Systematic Review and Meta-AnalysisPLOS ONE, 2009
- The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six monthsPharmacoepidemiology and Drug Safety, 2006
- Reduced Risk Factors for Vascular Disorders in Parkinson Disease PatientsStroke, 2006
- The influence of cerebrovascular risk factors on incident dementia in patients with Parkinson's diseaseActa Neurologica Scandinavica, 2005
- Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or olderJournal of Neurology, Neurosurgery & Psychiatry, 2003